Novel generating protective single nucleotide polymorphism barcode for breast cancer using particle swarm optimization

Cancer Epidemiology

Volumn 33, Issue 2, 2009, Pages 147-154

  Yang, Cheng Hong ^a   Chang, Hsueh Wei ^b   Cheng, Yu Huei ^a   Chuang, Li Yeh ^c  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

Author keywords

Binary particle swarm optimization; Odds ratio; Single nucleotide polymorphism; SNP interactions

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CLINICAL EVALUATION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HUMAN; PARTICLE SWARM OPTIMIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; AUTOMATIC DATA PROCESSING; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 68149144254     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.07.001     Document Type: Article

References (31)

1. Brookes A.J. The essence of SNPs. Gene 234 2 (1999) 177-186
2. Cantor C.R. The use of genetic SNPs as new diagnostic markers in preventive medicine. Ann N Y Acad Sci 1055 (2005) 48-57
3. Wang Y., and Armstrong S.A. Genome-wide SNP analysis in cancer: leukemia shows the way. Cancer Cell 11 4 (2007) 308-309
4. Roses A.D., Saunders A.M., Huang Y., Strum J., Weisgraber K.H., and Mahley R.W. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics J 7 1 (2007) 10-28
5. Xing J., Watkins W.S., Zhang Y., Witherspoon D.J., and Jorde L.B. High fidelity of whole-genome amplified DNA on high-density single nucleotide polymorphism arrays. Genomics 92 6 (2008) 452-456
6. Nishida N., Koike A., Tajima A., Ogasawara Y., Ishibashi Y., Uehara Y., et al. Evaluating the performance of Affymetrix SNP Array 6.0 platform with 400 Japanese individuals. BMC Genomics 9 (2008) 431
7. Hao K., Schadt E.E., and Storey J.D. Calibrating the performance of SNP arrays for whole-genome association studies. PLoS Genet 4 6 (2008) e1000109
8. Thorisson G.A., Smith A.V., Krishnan L., and Stein L.D. The International HapMap Project Web site. Genome Res 15 11 (2005) 1592-1593
9. Kang G., Yue W., Zhang J., Huebner M., Zhang H., Ruan Y., et al. Two-stage designs to identify the effects of SNP combinations on complex diseases. J Hum Genet 53 8 (2008) 739-746
10. Zabaleta J., Lin H.Y., Sierra R.A., Hall M.C., Clark P.E., Sartor O.A., et al. Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis 29 3 (2008) 573-578
11. Lin H.Y., Wang W., Liu Y.H., Soong S.J., York T.P., Myers L., et al. Comparison of multivariate adaptive regression splines and logistic regression in detecting SNP-SNP interactions and their application in prostate cancer. J Hum Genet 53 9 (2008) 802-811
12. Zheng S.L., Sun J., Wiklund F., Smith S., Stattin P., Li G., et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358 9 (2008) 910-919
13. Schabath M.B., Wu X., Wei Q., Li G., Gu J., and Spitz M.R. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev 15 1 (2006) 158-161
14. Miao X., Zhang X., Zhang L., Guo Y., Hao B., Tan W., et al. Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. Gastroenterology 131 2 (2006) 420-427
15. Ma H., Hu Z., Zhai X., Wang S., Wang X., Qin J., et al. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. Carcinogenesis 27 4 (2006) 766-771
16. Yen C.Y., Liu S.Y., Chen C.H., Tseng H.F., Chuang L.Y., Yang C.H., et al. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 37 5 (2008) 271-277
17. Lin G.T., Tseng H.F., Chang C.K., Chuang L.Y., Liu C.S., Yang C.H., et al. SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese women. Chin J Physiol 91 1 (2008) 1-10
18. Particle swarm optimization. Proceedings IEEE International Conference on Neural Networks, Perth, Australia; 1995.
19. Lin G.T., Tseng H.F., Yang C.H., Hou M.F., Chuang L.Y., Tai H.T., et al. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 13 2 (2009) 165-172
20. A discrete binary version of the particle swarm algorithm. Computational Cybernetics and Simulation, Proceedings IEEE Intl. Conf. on Systems, Man, and Cybernetic; 1997.
21. Defining a Standard for Particle Swarm Optimization. Proceedings of the 2007 IEEE Swarm Intelligence Symposium (SIS 2007); 2007.
22. Arya M., Ahmed H., Silhi N., Williamson M., and Patel H.R. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration. Tumour Biol 28 3 (2007) 123-131
23. Tilton B., Ho L., Oberlin E., Loetscher P., Baleux F., Clark-Lewis I., et al. Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med 192 3 (2000) 313-324
24. Chinni S.R., Sivalogan S., Dong Z., Filho J.C., Deng X., Bonfil R.D., et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 66 1 (2006) 32-48
25. Brand S., Dambacher J., Beigel F., Olszak T., Diebold J., Otte J.M., et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310 1 (2005) 117-130
26. Zhou Y., Yu C., Miao X., Tan W., Liang G., Xiong P., et al. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25 3 (2004) 399-404
27. Qiao D., Yi L., Hua L., Xu Z., Ding Y., Shi D., et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: a case-control study in Chinese Han population. J Cyst Fibros 7 3 (2008) 210-214
28. Liu Z., Calderon J.I., Zhang Z., Sturgis E.M., Spitz M.R., and Wei Q. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics 15 3 (2005) 159-165
29. Flugge J., Krusekopf S., Goldammer M., Osswald E., Terhalle W., Malzahn U., et al. Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol 63 11 (2007) 997-1005
30. Aberle J., Hopfer I., Beil F.U., and Seedorf U. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int J Obes (Lond) 30 12 (2006) 1709-1713
31. Baier R.J., Loggins J., and Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated Very Low Birth Weight infants. BMC Med 4 1 (2006) 10